Table 1

Age-Adjusted Incidence Rates, Incidence Rate Ratio, and Prevalence Rate with 95% Confidence Intervals (95% CI) for Primary Higher-grade Brainstem Glioma in Children and Adolescents (age ≤19 years) 2000-2017, CBTRUS (N = 4,486).

Total Patients 2000-2017 (%)Ratea95% Confidence Interval (CI)Incidence Rate Ratio (95% CI)P-valuePrevalence Rate (95% CI)
Overall4,4860.3050.296-0.3141.49 (1.40-1.57)
Sex
Males2,162 (48.2)0.2880.276-0.3001.50 (1.39-1.62)
Females2,324 (51.8)0.3240.311-0.3371.13 (1.06-1.19)<.0011.47 (1.36-1.59)
Race
White3,439 (76.7)0.2340.226-0.2421.62 (1.57-1.67)
Black750 (16.7)0.0510.048-0.0550.22 (0.20-0.24)<.0010.72 (0.66-0.78)
Other297 (6.6)0.0200.018-0.0230.08 (0.07-0.09)<.0010.99 (0.91-1.08)
Ethnicity
Hispanic914 (19.7)0.2830.265-0.3020.89 (0.81-0.96)
Non-Hispanic3,735 (80.3)0.3250.315-0.3361.14 (1.06-1.23)<.0011.60 (1.55-1.65)
Age at Diagnosis
<1 year80 (1.8)0.1110.088-0.1380.12 (0.04-0.29)
01-04 years1,093 (24.4)0.3810.359-0.4043.43 (2.73-4.36)<.0010.58 (0.47-0.71)
05-09 years1,843 (41.1)0.5080.485-0.5314.56 (3.65-5.78)<.0011.68 (1.51-1.87)
10-14 years944 (21.0)0.2500.235-0.2672.25 (1.79-2.86)<.0011.76 (1.58-1.95)
15-19 years526 (11.7)0.1370.125-0.1491.23 (0.97-1.57).0931.97 (1.78-2.17)
Gradeb
Radiographic confirmation onlyc3,101 (69.1)0.2110.204-0.219
Grade 3171 (3.8)0.0120.010-0.0130.055 (0.047-0.064)<.001
Grade 4320 (7.1)0.0220.020-0.0240.104 (0.092-0.116)<.001
Unknownd894 (19.9)0.0610.057-0.0650.288 (0.267-0.310)<.001
Total Patients 2000-2017 (%)Ratea95% Confidence Interval (CI)Incidence Rate Ratio (95% CI)P-valuePrevalence Rate (95% CI)
Overall4,4860.3050.296-0.3141.49 (1.40-1.57)
Sex
Males2,162 (48.2)0.2880.276-0.3001.50 (1.39-1.62)
Females2,324 (51.8)0.3240.311-0.3371.13 (1.06-1.19)<.0011.47 (1.36-1.59)
Race
White3,439 (76.7)0.2340.226-0.2421.62 (1.57-1.67)
Black750 (16.7)0.0510.048-0.0550.22 (0.20-0.24)<.0010.72 (0.66-0.78)
Other297 (6.6)0.0200.018-0.0230.08 (0.07-0.09)<.0010.99 (0.91-1.08)
Ethnicity
Hispanic914 (19.7)0.2830.265-0.3020.89 (0.81-0.96)
Non-Hispanic3,735 (80.3)0.3250.315-0.3361.14 (1.06-1.23)<.0011.60 (1.55-1.65)
Age at Diagnosis
<1 year80 (1.8)0.1110.088-0.1380.12 (0.04-0.29)
01-04 years1,093 (24.4)0.3810.359-0.4043.43 (2.73-4.36)<.0010.58 (0.47-0.71)
05-09 years1,843 (41.1)0.5080.485-0.5314.56 (3.65-5.78)<.0011.68 (1.51-1.87)
10-14 years944 (21.0)0.2500.235-0.2672.25 (1.79-2.86)<.0011.76 (1.58-1.95)
15-19 years526 (11.7)0.1370.125-0.1491.23 (0.97-1.57).0931.97 (1.78-2.17)
Gradeb
Radiographic confirmation onlyc3,101 (69.1)0.2110.204-0.219
Grade 3171 (3.8)0.0120.010-0.0130.055 (0.047-0.064)<.001
Grade 4320 (7.1)0.0220.020-0.0240.104 (0.092-0.116)<.001
Unknownd894 (19.9)0.0610.057-0.0650.288 (0.267-0.310)<.001

aIncidence and Prevalence rates are per 100,000 and are age-adjusted to the 2000 US standard population.

bPrevalence could not be reliably estimated due to the low sample size.

cIncludes unknown grade patients.

dIncludes histologically confirmed, but unknown WHO grade patients.

Table 1

Age-Adjusted Incidence Rates, Incidence Rate Ratio, and Prevalence Rate with 95% Confidence Intervals (95% CI) for Primary Higher-grade Brainstem Glioma in Children and Adolescents (age ≤19 years) 2000-2017, CBTRUS (N = 4,486).

Total Patients 2000-2017 (%)Ratea95% Confidence Interval (CI)Incidence Rate Ratio (95% CI)P-valuePrevalence Rate (95% CI)
Overall4,4860.3050.296-0.3141.49 (1.40-1.57)
Sex
Males2,162 (48.2)0.2880.276-0.3001.50 (1.39-1.62)
Females2,324 (51.8)0.3240.311-0.3371.13 (1.06-1.19)<.0011.47 (1.36-1.59)
Race
White3,439 (76.7)0.2340.226-0.2421.62 (1.57-1.67)
Black750 (16.7)0.0510.048-0.0550.22 (0.20-0.24)<.0010.72 (0.66-0.78)
Other297 (6.6)0.0200.018-0.0230.08 (0.07-0.09)<.0010.99 (0.91-1.08)
Ethnicity
Hispanic914 (19.7)0.2830.265-0.3020.89 (0.81-0.96)
Non-Hispanic3,735 (80.3)0.3250.315-0.3361.14 (1.06-1.23)<.0011.60 (1.55-1.65)
Age at Diagnosis
<1 year80 (1.8)0.1110.088-0.1380.12 (0.04-0.29)
01-04 years1,093 (24.4)0.3810.359-0.4043.43 (2.73-4.36)<.0010.58 (0.47-0.71)
05-09 years1,843 (41.1)0.5080.485-0.5314.56 (3.65-5.78)<.0011.68 (1.51-1.87)
10-14 years944 (21.0)0.2500.235-0.2672.25 (1.79-2.86)<.0011.76 (1.58-1.95)
15-19 years526 (11.7)0.1370.125-0.1491.23 (0.97-1.57).0931.97 (1.78-2.17)
Gradeb
Radiographic confirmation onlyc3,101 (69.1)0.2110.204-0.219
Grade 3171 (3.8)0.0120.010-0.0130.055 (0.047-0.064)<.001
Grade 4320 (7.1)0.0220.020-0.0240.104 (0.092-0.116)<.001
Unknownd894 (19.9)0.0610.057-0.0650.288 (0.267-0.310)<.001
Total Patients 2000-2017 (%)Ratea95% Confidence Interval (CI)Incidence Rate Ratio (95% CI)P-valuePrevalence Rate (95% CI)
Overall4,4860.3050.296-0.3141.49 (1.40-1.57)
Sex
Males2,162 (48.2)0.2880.276-0.3001.50 (1.39-1.62)
Females2,324 (51.8)0.3240.311-0.3371.13 (1.06-1.19)<.0011.47 (1.36-1.59)
Race
White3,439 (76.7)0.2340.226-0.2421.62 (1.57-1.67)
Black750 (16.7)0.0510.048-0.0550.22 (0.20-0.24)<.0010.72 (0.66-0.78)
Other297 (6.6)0.0200.018-0.0230.08 (0.07-0.09)<.0010.99 (0.91-1.08)
Ethnicity
Hispanic914 (19.7)0.2830.265-0.3020.89 (0.81-0.96)
Non-Hispanic3,735 (80.3)0.3250.315-0.3361.14 (1.06-1.23)<.0011.60 (1.55-1.65)
Age at Diagnosis
<1 year80 (1.8)0.1110.088-0.1380.12 (0.04-0.29)
01-04 years1,093 (24.4)0.3810.359-0.4043.43 (2.73-4.36)<.0010.58 (0.47-0.71)
05-09 years1,843 (41.1)0.5080.485-0.5314.56 (3.65-5.78)<.0011.68 (1.51-1.87)
10-14 years944 (21.0)0.2500.235-0.2672.25 (1.79-2.86)<.0011.76 (1.58-1.95)
15-19 years526 (11.7)0.1370.125-0.1491.23 (0.97-1.57).0931.97 (1.78-2.17)
Gradeb
Radiographic confirmation onlyc3,101 (69.1)0.2110.204-0.219
Grade 3171 (3.8)0.0120.010-0.0130.055 (0.047-0.064)<.001
Grade 4320 (7.1)0.0220.020-0.0240.104 (0.092-0.116)<.001
Unknownd894 (19.9)0.0610.057-0.0650.288 (0.267-0.310)<.001

aIncidence and Prevalence rates are per 100,000 and are age-adjusted to the 2000 US standard population.

bPrevalence could not be reliably estimated due to the low sample size.

cIncludes unknown grade patients.

dIncludes histologically confirmed, but unknown WHO grade patients.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close